How to Ease the Withdrawal of Tranquilizers Among Older Consumers?
Drug Dependence

About this trial
This is an interventional treatment trial for Drug Dependence focused on measuring Benzodiazepine withdrawal, PASSE-65+ program, Psychosocial (non-pharmacological) intervention, Cognitive-Behavioral Therapy (CBT), Older adults
Eligibility Criteria
Inclusion Criteria:
- Be aged 65 years and older;
- To consume benzodiazepine for at least two years (even if consumption is not continuous);
- Want to quit benzodiazepine use.
Exclusion Criteria:
- Living a difficult situation that requires specific interventions (e.g. bereavement or death, a recent breakup or suicidal thoughts);
- Alcohol or illicit drugs addiction (other than benzodiazepine);
- BZD use for medical reasons (e.g. epilepsy);
- Be unable to complete the questionnaires or to attend meetings for any reason (e.g. Loss of vision, severe arthritis, cognitive impairment, etc.).
Sites / Locations
- Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Experimental
No contact intervention
a weekly physician intervention
psychosocial intervention
Informative document that proposes a 12-week self-withdrawal grid
Informative document + 12 meetings (once a week; 30 minutes) with a physician who will supervise the gradual withdrawal
Informative document + 12 meetings (once a week; 30 minutes) with a physician who will supervise the gradual withdrawal + psychosocial intervention (PASSE-65+ program: 12 sessions over 16 weeks)